A European regulatory committee now recommends approval of the Alzheimer's treatment lecanemab a few months after rejecting ...

The European Union's drugs regulator on Thursday said it recommends approval of Eisai and Biogen's Leqembi in patients with ...

Europe's medicines watchdog on Thursday partially approved a marketing request for a long-awaited new treatment for Alzheimer ...

The European Union's drugs regulator on Thursday recommended approval of Eisai and Biogen's Leqembi for some patients with ...

The AD risk factors/hits include high exposure to traffic-related air pollution (TRAP) and infections, as well as factors ...

A breakthrough in the fight against Alzheimer’s disease may have been made in Seattle. Researchers at the Allen Institute ...

A multitude of genes have been linked to the development of Alzheimer's disease. Specifically how those genes might influence ...

November is National Alzheimer’s Disease Month, and it’s also Caretaker Month. These two things often go hand-in-hand, but ...

The European Union's drugs regulator reversed its decision to block the Alzheimer's drug lecanemab, a treatment aimed at ...

An international collaboration led by RIKEN researchers has discovered how unusual spherical structures form in the brains of ...

Researchers at Texas A&M University have developed a nasal spray shown to delay disease progression in animals -- fueling ...

A key regulatory committee sided against the drug this summer. But an appeal from Eisai appears to have worked, teeing ...